Chemoresistance: The hidden barrier in cancer treatment
Authors:
Open Access
- 5 July 2025
- journal article
- review article
- Published by Elsevier in Cancer Pathogenesis and Therapy
- Vol. 4 (2) , 98-109
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Phytomediated Chitosan‐Modified TiO 2 NPs for Enhanced Photocatalytic and Potential Application for Breast Cancer TherapyLuminescence, 2025
- The critical role of X-linked inhibitor of apoptosis protein (XIAP) in tumor developmentApoptosis, 2025
- A comprehensive overview of radiation therapy impacts of various cancer treatments and pivotal role in the immune systemCell Biochemistry and Function, 2024
- Tumor suppressor p53: Biology, signaling pathways, and therapeutic targetingBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Potential role of exosomes in cancer therapyPrecision Radiation Oncology, 2019
- Mitochondria and cancer chemoresistanceBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2017
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumorsInvestigational New Drugs, 2016
- Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222Tumor Biology, 2015
- PX‐478, an inhibitor of hypoxia‐inducible factor‐1α, enhances radiosensitivity of prostate carcinoma cellsInternational Journal of Cancer, 2008
- Chemoresistance in gliomasMolecular and Cellular Biochemistry, 2008